Mark Leuchtenberger

Mark Leuchtenberger is Chief Executive Officer at SpyBiotech. Mark has a history of c-suite company leadership, including Chairman positions at Neurosense Therapeutics and Aleta Biotherapeutics, as well as President & CEO roles at IRX Therapeutics and Chiasma. He attended Wake Forest University and the Yale School of Management.